TechPrecision Corporation, through its wholly-owned subsidiary Ranor, Inc., produces high-precision, large scale metal fabrications and machined assemblies weighing up to 100 tons. A significant part of the Company’s revenues are derived from the alternative energy industry. The Company also manufactures products for the aerospace/defense, medical and other commercial industries. TechPrecision is one of a few end-to-end solutions providers with the ability to engineer the requisite tooling and the entire manufacturing process for each respective production program, fabricate, machine, assemble, test and deliver large scale projects with tight tolerance levels. The Company is a highly valuable contractor in all industry sectors due to leveraging its expertise from over 50 years of developing mission critical products for the aerospace and defense industries to meet exacting requirements for high pressure, strength, and precision metal fabrications. TechPrecision’s wholly-owned subsidiary Ranor, Inc. is one of the few facilities in the U.S. with Certifications and Authorizations issued by the American Society of Mechanical Engineers (ASME), which allow the design and construction of commercial nuclear equipment, and nuclear storage and transportation equipment.
Why Invest in TechPrecision Corporation?
- Fifty plus year history of manufacturing components with high tolerances to rigorous standards
- Refocused toward the solar, nuclear and medical industries
- Focus on projects with more predictable cost structures
- Increasingly efficient business model with growing margins
- Advanced facilities and certifications create a high barrier of entry for competitors
- Strong and growing backlog
First Quarter of Fiscal 2009 Highlights
- Net sales increased 77.9% to $11.7 million
- Gross profit rose 101.7% to $3.4 million
- Gross profit margin was 29.0%
- Operating income increased 126.7% to $2.8 million
- Net income increased 129.5% to $1.6 million
- Net income per common share was $0.12 and $0.06 basic and diluted, versus $0.07 and $0.04 basic and diluted for the first quarter of the previous year.